Blog
Levels of risk in human subjects research
Investigators may have noticed that there seems to be a high degree of variability in Institutional review board (IRB) reviews, both in review type and approval requirements.Several regulations must be considered when reviewing a study. IRBs are given discretion to...
Emergency Use of a Test Article: Types and Regulations
The COVID-19 pandemic has brought up questions regarding the emergency use of drugs, devices, and/or biologics. What issues must investigators understand prior to submission of a study to the Institutional Review Board (IRB) for review? Below is a brief...
COVID-19 Clinical Trial Considerations
At PRIM&R's 2014 Advancing Ethical Research Conference, Dr. Anthony Fauci gave a keynote address where he shared his personal account of the ethical challenges of research during the HIV/AIDS epidemic. The urgency and fear that surround an outbreak...
OHRP Issues Guidance on COVID-19 for the Research Community
The Office for Human Research Protections (OHRP) has released guidance regarding how the Common Rule regulations should be applied in response to the COVID-19 outbreak. Given the current circumstances, “the research community is encouraged to prioritize...
COVID-19 Clinical Trials
With the pandemic of COVID-19 affecting the way of life across the globe, companies continue to accelerate the clinical development of a vaccine or a therapeutic. The number of Covid-19 clinical trials has been steadily growing because of the increases in...